Cargando…

Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response

OBJECTIVES: An observational study to evaluate the relationship between serum concentrations of adalimumab and disease activity in patients receiving long-term adalimumab treatment for psoriatic arthritis. METHODS: Serum adalimumab and adalimumab antidrug antibodies were quantified by enzyme linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chimenti, Maria Sole, Triggianese, Paola, Narcisi, Alessandra, Marinari, Barbara, Teoli, Miriam, Faleri, Sara, Arcese, Annalisa, Perricone, Roberto, Costanzo, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Immuno-Mediated Diseases and Treatment Immunogenicity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536527/ https://www.ncbi.nlm.nih.gov/pubmed/27683139 http://dx.doi.org/10.1177/0300060515593235

Ejemplares similares

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study
por: Potenza, Concetta, et al.
Publicado: (2016)

S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

How the immune system responds to therapeutic biological agents
por: Vultaggio, Alessandra, et al.
Publicado: (2016)

Long-term safety of etanercept in psoriasis: Retrospective study focused on infections
por: Orsini, Diego, et al.
Publicado: (2016)

Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study
por: Teoli, M., et al.
Publicado: (2012)

Suicide risk and psychiatric comorbidity in patients with psoriasis
por: Pompili, Maurizio, et al.
Publicado: (2016)

Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
por: Giunta, Alessandro, et al.
Publicado: (2016)

Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
por: De Simone, Clara, et al.
Publicado: (2016)

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation
por: Spinelli, Francesca Romana, et al.
Publicado: (2016)

Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case–control study
por: Erre, Gian Luca, et al.
Publicado: (2016)

Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study
por: Chimenti, Maria Sole, et al.
Publicado: (2019)

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
por: D'Angelo, Salvatore, et al.
Publicado: (2019)

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
por: Mease, P J, et al.
Publicado: (2008)

Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis
por: Murdaca, Giuseppe, et al.
Publicado: (2016)

Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example
por: Lai, Zhihong, et al.
Publicado: (2016)

PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study
por: Chimenti, Maria Sole, et al.
Publicado: (2019)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2020)

Adalimumab in the treatment of arthritis
por: Mease, Philip J
Publicado: (2007)

Profile of certolizumab and its potential in the treatment of psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2013)

Granulomatous interstitial nephritis secondary to adalimumab therapy
por: Sandys, Vicki, et al.
Publicado: (2018)

Psoriatic Arthritis in Males and Females: Differences and Similarities
por: Lubrano, Ennio, et al.
Publicado: (2023)

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
por: Landewé, Robert, et al.
Publicado: (2019)

Brain abscess in a patient with psoriatic arthritis treated with adalimumab: A case report
por: Lo, Yu-Pei, et al.
Publicado: (2020)

Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020)

The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis – preliminary report
por: Krawczyk, Agata, et al.
Publicado: (2021)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation †
por: Chimenti, Maria Sole, et al.
Publicado: (2020)

Identification of HLA-DRB1 association to adalimumab immunogenicity
por: Liu, Mohan, et al.
Publicado: (2018)

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis
por: Alten, Rieke, et al.
Publicado: (2020)

Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis
por: Bergamini, Alberto, et al.
Publicado: (2014)

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
por: Mease, Philip, et al.
Publicado: (2020)

Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
por: Strand, Vibeke, et al.
Publicado: (2017)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
por: Gladman, Dafna D., et al.
Publicado: (2022)

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
por: Christensen, Ingrid Egeland, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_42c2ousfk3vbh7ugrso307urek